scholarly journals Alcohol Induced Gut Microbiota Modulation: The Role of Probiotics, Pufas, and Vitamin E in Management of Alcoholic Liver Disease

2021 ◽  
Vol 05 (13) ◽  
Author(s):  
Faruqui AA
Keyword(s):  
Liver Disease ◽  
Vitamin E ◽  
Gut Microbiota ◽  
Alcoholic Liver Disease

scholarly journals Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites

2019 ◽  
Vol 141 ◽  
pp. 521-529 ◽  
Author(s):  
Yufang Ding ◽  
Karin Yanagi ◽  
Clint Cheng ◽  
Robert C. Alaniz ◽  
Kyongbum Lee ◽  
...  
Keyword(s):  
Liver Disease ◽  
Gut Microbiota ◽  
Alcoholic Liver Disease

Review article: alcohol and gut microbiota - the possible role of gut microbiota modulation in the treatment of alcoholic liver disease

2015 ◽  
Vol 41 (10) ◽  
pp. 917-927 ◽  
Author(s):  
G. Vassallo ◽  
A. Mirijello ◽  
A. Ferrulli ◽  
M. Antonelli ◽  
R. Landolfi ◽  
...  
Keyword(s):  
Liver Disease ◽  
Gut Microbiota ◽  
Alcoholic Liver Disease ◽  
Review Article

Gut Microbiota and Alcoholic Liver Disease

2016 ◽  
Vol 11 (3) ◽  
pp. 213-219 ◽  
Author(s):  
Emidio Scarpellini ◽  
Forlino Mariana ◽  
Lupo Marinella ◽  
Rasetti Carlo ◽  
Fava Giammarco ◽  
...  
Keyword(s):  
Liver Disease ◽  
Gut Microbiota ◽  
Alcoholic Liver Disease

scholarly journals Modulation of gut microbiota mediates berberine‐induced expansion of immuno‐suppressive cells to against alcoholic liver disease

2020 ◽  
Vol 10 (4) ◽  
Author(s):  
Sha Li ◽  
Ning Wang ◽  
Hor‐Yue Tan ◽  
Fan Chueng ◽  
Zhang‐Jin Zhang ◽  
...  
Keyword(s):  
Liver Disease ◽  
Gut Microbiota ◽  
Alcoholic Liver Disease

Regulatory effect of volatile compounds in fermented alcoholic beverages on gut microbiota and serum metabolism in mouse model

2021 ◽  
Author(s):  
Mei Ji ◽  
Cheng Fang ◽  
Wei Jia ◽  
Hai Du ◽  
Yan Xu
Keyword(s):  
Risk Factor ◽  
Liver Disease ◽  
Mouse Model ◽  
Gut Microbiota ◽  
Volatile Compounds ◽  
Alcoholic Liver Disease ◽  
Alcoholic Beverages ◽  
Regulatory Effect ◽  
Main Risk Factor

Ethanol (EtOH) is the main risk factor for alcoholic liver disease. However, fermented alcoholic beverages contain not only ethanol but also various volatile compounds. Currently, effects of volatile compounds in...

scholarly journals The Role of the Gut Microbiome in Liver Cirrhosis Treatment

2020 ◽  
Vol 22 (1) ◽  
pp. 199
Author(s):  
Na Young Lee ◽  
Ki Tae Suk
Keyword(s):  
Liver Cirrhosis ◽  
Liver Disease ◽  
Liver Fibrosis ◽  
Gut Microbiota ◽  
Gut Microbiome ◽  
Liver Diseases ◽  
Sclerosing Cholangitis ◽  
Chronic Liver ◽  
Chronic Liver Diseases

Liver cirrhosis is one of the most prevalent chronic liver diseases worldwide. In addition to viral hepatitis, diseases such as steatohepatitis, autoimmune hepatitis, sclerosing cholangitis and Wilson’s disease can also lead to cirrhosis. Moreover, alcohol can cause cirrhosis on its own and exacerbate chronic liver disease of other causes. The treatment of cirrhosis can be divided into addressing the cause of cirrhosis and reversing liver fibrosis. To this date, there is still no clear consensus on the treatment of cirrhosis. Recently, there has been a lot of interest in potential treatments that modulate the gut microbiota and gut-liver axis for the treatment of cirrhosis. According to recent studies, modulation of the gut microbiome by probiotics ameliorates the progression of liver disease. The precise mechanism for relieving cirrhosis via gut microbial modulation has not been identified. This paper summarizes the role and effects of the gut microbiome in cirrhosis based on experimental and clinical studies on absorbable antibiotics, probiotics, prebiotics, and synbiotics. Moreover, it provides evidence of a relationship between the gut microbiome and liver fibrosis.

The interplay between gut microbiota and the immune system in liver transplant recipients and its role in infections

2021 ◽  
Author(s):  
Giuseppe Ancona ◽  
Laura Alagna ◽  
Andrea Lombardi ◽  
Emanuele Palomba ◽  
Valeria Castelli ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Immune System ◽  
Liver Disease ◽  
Gut Microbiota ◽  
Liver Transplant ◽  
Bacterial Infections ◽  
Multidrug Resistant ◽  
Transplant Recipients ◽  
Liver Transplant Recipients

Liver transplantation (LT) is a life-saving strategy for patients with end-stage liver disease, hepatocellular carcinoma and acute liver failure. LT success can be hampered by several short-term and long-term complications. Among them, bacterial infections, especially due to multidrug-resistant germs, are particularly frequent with a prevalence between 19 and 33% in the first 100 days after transplantation. In the last decades, a number of studies have highlighted how gut microbiota (GM) is involved in several essential functions to ensure the intestinal homeostasis, becoming one of the most important virtual metabolic organs. GM works through different axes with other organs, and the gut-liver axis is among the most relevant and investigated ones. Any alteration or disruption of GM is defined as dysbiosis. Peculiar phenotypes of GM dysbiosis have been associated to several liver conditions and complications, such as chronic hepatitis, fatty liver disease, cirrhosis and hepatocellular carcinoma. Moreover, there is growing evidence of the crucial role of GM in shaping the immune response, both locally and systemically, against pathogens. This paves the way to the manipulation of GM as a therapeutic instrument to modulate the infectious risk and outcome. In this minireview we provide an overview of the current understanding on the interplay between gut microbiota and the immune system in liver transplant recipients and the role of the former in infections.

Sign in / Sign up

Export Citation Format

Share Document